SCND — Scientific Industries Income Statement
0.000.00%
Last trade - 00:00- $9.08m
- $2.42m
- $5.05m
Annual income statement for Scientific Industries, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 9.78 | 11.4 | 11.1 | 4.8 | 5.05 |
| Cost of Revenue | |||||
| Gross Profit | 4.98 | 5.74 | 5.1 | 2.01 | 1.3 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 14.5 | 19.1 | 20.4 | 13 | 12.9 |
| Operating Profit | -4.71 | -7.7 | -9.26 | -8.22 | -7.89 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -4.05 | -7 | -9.09 | -8.02 | -1.78 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.11 | -5.65 | -9.09 | -8.02 | -1.78 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -3.67 | -5.64 | -9.09 | -6.45 | -1.22 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.67 | -5.64 | -9.09 | -6.45 | -1.22 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.975 | -0.809 | -0.896 | -0.764 | -0.442 |